Showing results (3831-3840 of 9,925) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 3, 2004
Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in KoreaJ-H Yoo, D-G Lee, S M Choi, et al.
Bone Marrow Transplantation|August 3, 2004
Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myelomaO F Ballester, T Fang, A Raptis, et al.
Bone Marrow Transplantation|August 3, 2004
Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2Y-C Shen, C-F Chiu, K-C Chow, et al.
Bone Marrow Transplantation|July 27, 2004
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease responseP Anderlini, S A Acholonu, G-J Okoroji, et al.
Bone Marrow Transplantation|July 27, 2004
Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantationA Spyridonidis, A K Thomas, H Bertz, et al.
Bone Marrow Transplantation|August 23, 2005
Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumabK Oshima, M Sakata-Yanagimoto, Y Asano-Mori, et al.
Bone Marrow Transplantation|August 23, 2005
Dental abnormalities after pediatric bone marrow transplantationM D Vaughan, C C Rowland, X Tong, et al.
Bone Marrow Transplantation|August 23, 2005
Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experienceG J Ruiz-Argüelles, A Morales-Toquero, B López-Martínez, et al.
Bone Marrow Transplantation|August 23, 2005
Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemiasG Massenkeil, M Nagy, S Neuburger, et al.
Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.
Pageof 993